Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M van Rijn

Showing results (11-20 of 354) with videos related to

Pageof 36
Sort By:
Pharmacological Research|February 1, 2022
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effectsAlexander R French, Richard M van Rijn
Epilepsia|April 10, 2008
Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling modelLyudmila V Vinogradova, Clementina M van Rijn
The Annals of Otology, Rhinology, and Laryngology|July 1, 1988
Surgery for congenital conductive deafness in Klippel-Feil syndromeP M van Rijn, C W Cremers
Neuropharmacology|April 2, 2023
Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizuresArryn T Blaine, Richard M van Rijn
Pharmacological Reports : PR|May 3, 2015
Long-term disease-modifying effect of the endocannabinoid agonist WIN55,212-2 in a rat model of audiogenic epilepsyLyudmila V Vinogradova, Clementina M van Rijn
The Annals of Otology, Rhinology, and Laryngology|November 1, 1991
Causes of childhood deafness at a Dutch school for the hearing impairedP M van Rijn, C W Cremers
Medical Problems of Performing Artists|June 2, 2020
Characteristics, Properties, and Associations of Self-Assessed Pain Questionnaires: A Literature Review and Prospective Cohort Study Among Dance StudentsRogier M van Rijn, Janine H Stubbe
Biological Psychiatry|July 7, 2009
The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intakeRichard M van Rijn, Jennifer L Whistler
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid ReceptorsYazan J Meqbil, Richard M van Rijn
Frontiers in Cellular Neuroscience|September 3, 2019
Response: Commentary: Commonly Used Anesthesia/Euthanasia Methods for Brain Collection Differentially Impact MAPK Activity in Male and Female C57BL/6 MiceMee Jung Ko, Richard M van Rijn
Pageof 36

Showing results (11-20 of 354) with videos related to

Sort By:
Pageof 36
Pharmacological Research|February 1, 2022
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effectsAlexander R French, Richard M van Rijn
Epilepsia|April 10, 2008
Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling modelLyudmila V Vinogradova, Clementina M van Rijn
The Annals of Otology, Rhinology, and Laryngology|July 1, 1988
Surgery for congenital conductive deafness in Klippel-Feil syndromeP M van Rijn, C W Cremers
Neuropharmacology|April 2, 2023
Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizuresArryn T Blaine, Richard M van Rijn
Pharmacological Reports : PR|May 3, 2015
Long-term disease-modifying effect of the endocannabinoid agonist WIN55,212-2 in a rat model of audiogenic epilepsyLyudmila V Vinogradova, Clementina M van Rijn
The Annals of Otology, Rhinology, and Laryngology|November 1, 1991
Causes of childhood deafness at a Dutch school for the hearing impairedP M van Rijn, C W Cremers
Medical Problems of Performing Artists|June 2, 2020
Characteristics, Properties, and Associations of Self-Assessed Pain Questionnaires: A Literature Review and Prospective Cohort Study Among Dance StudentsRogier M van Rijn, Janine H Stubbe
Biological Psychiatry|July 7, 2009
The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intakeRichard M van Rijn, Jennifer L Whistler
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid ReceptorsYazan J Meqbil, Richard M van Rijn
Frontiers in Cellular Neuroscience|September 3, 2019
Response: Commentary: Commonly Used Anesthesia/Euthanasia Methods for Brain Collection Differentially Impact MAPK Activity in Male and Female C57BL/6 MiceMee Jung Ko, Richard M van Rijn
Pageof 36